RIVA-RISEDRONATE
LABORATOIRE RIVA INC.
Quick answers
Is there a shortage of RIVA-RISEDRONATE in Canada?
No. There is no current shortage of RIVA-RISEDRONATE 35MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ACTONEL
ABBVIE CORPORATION
PHL-RISEDRONATE
PHARMEL INC
DOM-RISEDRONATE
DOMINION PHARMACAL
PENDO-RISEDRONATE
PENDOPHARM DIVISION OF PHARMASCIENCE INC
Q-RISEDRONATE
QD PHARMACEUTICALS ULC
RATIO-RISEDRONATE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
DIN
02341077
Strength
35MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE)
See all RISEDRONATE SODIUM (RISEDRONATE SODIUM HEMIPENTAHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from LABORATOIRE RIVA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
160MG · DIN 02017431
80MG · DIN 02017458
DIN 02154234
500MG · DIN 02362201
325MG · DIN 02362198
500MG · DIN 02362228
325MG · DIN 02022214
500MG · DIN 02022222
15MG · DIN 02009889
30MG · DIN 02009757
10000UNIT · DIN 00821772
DIN 02245592